|
Cost effectiveness of first-line treatment with doxorubicin/ifosfamide compared to trabectedin monotherapy in the management of advanced soft tissue sarcoma in Italy, Spain, and Sweden |
Guest JF, Panca M, Sladkevicius E, Gough N, Linch M |
|
|
Record Status This is an economic evaluation that meets the criteria for inclusion on NHS EED. Bibliographic details Guest JF, Panca M, Sladkevicius E, Gough N, Linch M. Cost effectiveness of first-line treatment with doxorubicin/ifosfamide compared to trabectedin monotherapy in the management of advanced soft tissue sarcoma in Italy, Spain, and Sweden. Sarcoma 2013; 2013: 725305 Indexing Status Subject indexing assigned by CRD MeSH Antineoplastic Combined Chemotherapy Protocols; Dioxoles; Doxorubicin; Humans; Ifosfamide; Italy; Sarcoma; Soft Tissue Neoplasms; Spain; Sweden AccessionNumber 22013052599 Date bibliographic record published 24/12/2013 |
|
|
|